Arkolith/Insider Trading/SRNE/Form 4

Ji Henry

See Remarks, DirectorSorrento Therapeutics, Inc. (SRNE) · full profile →Form 4 · filed Sep 7, 2022
Net Buying
Open-Market Buys
$180K
Open-Market Sells
$0
Net Open-Market Flow
$180K
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 7, 2022Buy(P)89K$2.02$180K4.8M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 7, 2022Buy(P)129$41.66$5K129
Sep 7, 2022Buy(P)759$40.66$31K759

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-049065) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML